Term ends Mar 7, 2041 · High confidence
20-year base term ends Feb 27, 2040
Held by Pfizer Inc. and Allogene Therapeutics, Inc.
Filed Apr 27, 2023 as application 18/308,143 · Granted Apr 21, 2026
Base term plus 579 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
2020
2041
Clock starts
Feb 27, 2020
Feb 27, 2020
Term ends
Mar 7, 2041
Mar 7, 2041
Granted
Apr 21, 2026
Apr 21, 2026
base term
patent term adjustment
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
579
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 11,673,953.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
3
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 579 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 0 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Feb 27, 2020, when application 16/802,822, the earliest non-provisional in its chain, was filed (this one was filed Apr 27, 2023) | Feb 27, 2040 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +579 days, USPTO patent term adjustment record | Sep 28, 2041 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 11,673,953) | capped to Mar 7, 2041 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Mar 7, 2041 | High confidence |
This family
| US 11,673,953 | In force Mar 2041 | Mar 2041 |
| US 12,606,623 | this patent Mar 2041 | Mar 2041 |
| Application 19/547,559 | Pending not computed | not computed |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jul 15, 2025 Reel 71710, frame 230 | Zhang, Yi; Van Blarcom, Thomas John; Panowski, Siler; Tacheva-grigorova, Silvia K.; Sasu, Barbra Johnson | Pfizer Inc.; Allogene Therapeutics, Inc. | Assignment of Assignor's Interest |
| Jul 15, 2025 reel/frame not recorded | Panowski, Siler; Tacheva-grigorova, Silvia K.; Van Blarcom, Thomas John; Zhang, Yi; Sasu, Barbra Johnson | Pfizer Inc. | Assignment of Assignor's Interest |
| Jul 15, 2025 reel/frame not recorded | Panowski, Siler; Tacheva-grigorova, Silvia K.; Van Blarcom, Thomas John; Zhang, Yi; Sasu, Barbra Johnson | Allogene Therapeutics, Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Mar 2041
Term ends Mar 7, 2041. Maintenance fees still fall due before then
Note
The 579 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Disclaimer cap
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 11,673,953.
Citations
We have no citation count for this patent yet. That is not the same as never having been cited.
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.